These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38803986)

  • 1. Response to a letter to the editor, "Studying the incidence of thyroid cancer in Ecuador: 2016-2021".
    Paz-Cruz E; Cadena-Ullauri S; Guevara-Ramírez P; Ruiz-Pozo VA; Tamayo-Trujillo R; Simancas-Racines D; Zambrano AK
    Heliyon; 2024 May; 10(10):e30963. PubMed ID: 38803986
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    Solis-Pazmino P; Salazar-Vega J; Lincango-Naranjo E; Garcia C; Koupermann GJ; Ortiz-Prado E; Ledesma T; Rojas T; Alvarado-Mafla B; Carcamo C; Ponce OJ; Brito JP
    BMC Cancer; 2021 Jan; 21(1):42. PubMed ID: 33419403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid Cancer in Ecuador, a 16 years population-based analysis (2001-2016).
    Salazar-Vega J; Ortiz-Prado E; Solis-Pazmino P; Gómez-Barreno L; Simbaña-Rivera K; Henriquez-Trujillo AR; Brito JP; Toulkeridis T; Coral-Almeida M
    BMC Cancer; 2019 Apr; 19(1):294. PubMed ID: 30940122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid cancer in Ecuador.
    López Gavilanez E; Bautista Litardo N; Navarro Chávez M; Hernández Bonilla M; Segale Bajaña A
    BMC Cancer; 2020 Jul; 20(1):637. PubMed ID: 32646384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid cancer in Ecuador: A genetic variants review and a cross-sectional population-based analysis before and after COVID-19 pandemic.
    Paz-Cruz E; Cadena-Ullauri S; Guevara-Ramírez P; Ruiz-Pozo VA; Tamayo-Trujillo R; Simancas-Racines D; Zambrano AK
    Heliyon; 2024 Jan; 10(1):e23964. PubMed ID: 38226262
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Garrido D; Garrido S; González M; Pullas G
    High Alt Med Biol; 2021 Mar; 22(1):110-112. PubMed ID: 33047979
    [No Abstract]   [Full Text] [Related]  

  • 7. Studying the incidence of thyroid cancer in Ecuador: 2016-2021.
    Lopez Gavilanez E; Navarro Grijalva M
    Heliyon; 2024 May; 10(10):e30711. PubMed ID: 38784555
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and mortality from thyroid cancer in Latin America.
    de Morais Fernandes FCG; de Souza DLB; Curado MP; de Souza TA; de Almeida Medeiros A; Barbosa IR
    Trop Med Int Health; 2021 Jul; 26(7):800-809. PubMed ID: 33837603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to the Letter to the Editor 'Germline-somatic fluidity in guiding patient care. Reply to the Letter to the Editor "Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients" by J. C. Rubinstein et al.' by E. Hahn & G. S. Charames.
    Christison-Lagay ER; Rubinstein JC
    Ann Oncol; 2020 Aug; 31(8):1090-1091. PubMed ID: 32428551
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
    Pacheco-Ojeda LA; Martínez AL; Alvarez M
    Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to editor: A systematic review of the incidence of thyroid carcinoma in patients undergoing thyroidectomy for thyrotoxicosis.
    Edafe O; Balasubramanian SP
    Clin Otolaryngol; 2020 Nov; 45(6):963. PubMed ID: 32734704
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the Editor: Reoperation for Bleeding After Thyroid and Parathyroid Surgery: Incidence, Risk Factors, Prevention, and Management.
    Di Marco AN; Glover A; Sywak MS; Sidhu SB
    World J Surg; 2020 Jul; 44(7):2441-2442. PubMed ID: 32189032
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in cancer incidence and mortality over three decades in Quito - Ecuador.
    Corral Cordero F; Cueva Ayala P; Yépez Maldonado J; Tarupi Montenegro W
    Colomb Med (Cali); 2018 Mar; 49(1):35-41. PubMed ID: 29983462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to: Letter to the editor of heliyon re: "Diagnostic evaluation of nCoV-QS, nCoV-QM-N, and nCoV-OM detection kits based on rRT-PCR for detection of SARS-CoV-2 in Ecuador".
    Salinas M; Aguirre D; Baldeón L; Pérez-Galarza J
    Heliyon; 2023 Sep; 9(9):e19936. PubMed ID: 37727276
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to: Letter to the Editor Regarding "Validation of CT-Based Risk Stratification System for Lymph Node Metastasis in Patients With Thyroid Cancer".
    Roh YH; Chung SR
    Korean J Radiol; 2024 Mar; 25(3):323-324. PubMed ID: 38413117
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the Editor-ResponseResponse to Letter to the Editor: "Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center".
    Molinaro E; Campopiano C; Elisei R
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32396935
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to the Letter to the Editor: 'Absorbed radiation doses in the thyroid as estimated by UNSCEAR and subsequent risk of childhood thyroid cancer following the Great East Japan Earthquake', by Ohira et al.
    Ohira T; Shimura H; Yasumura S; Yokoya S; Ohto H; Kamiya K
    J Radiat Res; 2021 May; 62(3):425-426. PubMed ID: 33693686
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Letter to the Editor From Shijie Yang: "Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study".
    Wei Y; Zhao ZL; Wu J; Peng LL; Li Y; Lu NC; Yu MA
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1771-e1772. PubMed ID: 34791335
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to 'Letter to the Editor': The Clinical Value of (124)I PET/CT Imaging in Thyroid Cancer.
    Gulec S; Kuker R
    Thyroid; 2016 Aug; 26(8):1142-3. PubMed ID: 27296268
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Letter to the Editor From Yang et al: "Prevalence of Postoperatively Detected High-Risk Features in 2- to 4-cm Papillary Thyroid Cancers".
    Choi JH; Lee JK; Kim W; Yu HW; Kim SJ; Chai YJ; Choi JY; Lee KE
    J Clin Endocrinol Metab; 2023 Apr; 108(5):e198-e199. PubMed ID: 36611244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.